A novel role for inducible Fut2 in angiogenesis

Angiogenesis

Volumn 16, Issue 1, 2013, Pages 195-205

  Tsou, Pei Suen ^a   Ruth, Jeffrey H ^a   Campbell, Phillip L ^a   Isozaki, Takeo ^a   Lee, Solhee ^a   Marotte, Hubert ^a   Domino, Steven E ^a   Koch, Alisa E ^a,b   Amin, Mohammad A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Veteran's Administration   (United States)

Author keywords

Angiogenesis; bFGF; Endothelial cells; ERK1 2 phosphorylation; Fut2; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FUCOSYLTRANSFERASE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GRANULOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEOANGIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPONGE GRANULOMA; UPREGULATION;

ANIMALS; CELL MOVEMENT; COLLAGEN; DERMIS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMOGLOBINS; HUMANS; INTERLEUKIN-1BETA; LAMININ; LUNG; MICE; MICE, INBRED C57BL; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEOGLYCANS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

MUS;

EID: 84871531777     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9312-y     Document Type: Article

References (41)

1. de Vries T, Knegtel RM, Holmes EH, Macher BA (2001) Fucosyltransferases: structure/function studies. Glycobiology 11(10):119R-128R
2. Oriol R, Mollicone R, Coullin P, Dalix AM, Candelier JJ (1992) Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMIS Suppl 27:28-38
3. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376(6540):517-519. doi: 10.1038/376517a0
4. Lowe JB (1997) Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 51(5):1418-1426
5. Moehler TM, Sauer S, Witzel M, Andrulis M, Garcia-Vallejo JJ, Grobholz R, Willhauck-Fleckenstein M, Greiner A, Goldschmidt H, Schwartz-Albiez R (2008) Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis. J Cell Physiol 215(1):27-36
6. Amin MA, Rabquer BJ, Kumar P, Mansfield PJ, Campbell PL, Domino SE, Koch AE (2007) A unique role for cytokine inducible fucosyltransferase 1 in angiogenesis. Arthritis Rheum 56:S583
7. Nguyen M, Strubel NA, Bischoff J (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267-269
8. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270(9):4640-4649
9. Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270(9):4632-4639
10. Blackwell CC, Jonsdottir K, Hanson MF, Weir DM (1986) Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 2(8508):687
11. Blackwell CC, Jonsdottir K, Hanson M, Todd WT, Chaudhuri AK, Mathew B, Brettle RP, Weir DM (1986) Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 2(8501):284-285
12. Hiller KM, Mayben JP, Bendt KM, Manousos GA, Senger K, Cameron HS, Weston BW (2000) Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog 27(4):280-288
13. Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, Rosati F (2010) RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem 111(1):229-238. doi: 10.1002/jcb.22692
14. Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB (2001) Deficiency of reproductive tract alpha(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 alpha(1,2)fucosyltransferase locus. Mol Cell Biol 21(24):8336-8345
15. Domino SE, Zhang L, Lowe JB (2001) Molecular cloning, genomic mapping, and expression of two secretor blood group alpha (1,2)fucosyltransferase genes differentially regulated in mouse uterine epithelium and gastrointestinal tract. J Biol Chem 276(26):23748-23756
16. Marelli-Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI (2000) Isolation of endothelial cells from murine tissue. J Immunol Methods 244:205-215
17. Koch AE, Polverini PJ, Leibovich SJ (1986) Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29(4):471-479
18. Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93(4):321-329
19. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167(3):1644-1653
20. Fricke I, Mitchell D, Petersen F, Bohle A, Bulfone-Paus S, Brandau S (2004) Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 18(13):1588-1590. doi: 10.1096/fj.03-1435fje
21. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM, Kim PH (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81(2):557-566. doi: 10.1189/jlb.0806517
22. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307. doi: 10.1038/nature10144
23. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27-31
24. Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36(2):127-137
25. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18(1):26-45
26. Padro M, Mejias-Luque R, Cobler L, Garrido M, Perez-Garay M, Puig S, Peracaula R, de Bolos C (2011) Regulation of glycosyltransferases and Lewis antigens expression by IL-1beta and IL-6 in human gastric cancer cells. Glycoconj J 28(2):99-110. doi: 10.1007/s10719-011-9327-4
27. Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA (2011) Macrophages regulate expression of alpha1,2 fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod. doi: 10.1093/molehr/gar070
28. Wagers AJ, Kansas GS (2000) Potent induction of alpha(1,3)- fucosyltransferase VII in activated CD4 + T cells by TGF-beta 1 through a p38 mitogen-activated protein kinase-dependent pathway. J Immunol 165(9):5011-5016
29. Schnyder-Candrian S, Borsig L, Moser R, Berger EG (2000) Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci U S A 97(15):8369-8374
30. Hallouin F, Goupille C, Bureau V, Meflah K, Le Pendu J (1999) Increased tumorigenicity of rat colon carcinoma cells after alpha1,2-fucosyltransferase FTA anti-sense cDNA transfection. Int J Cancer 80(4):606-611. doi: 10.1002/(SICI)1097-0215(19990209)80
31. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54(23):6275-6281
32. Domino SE, Karnak DM, Hurd EA (2007) Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation. Tumour Biol 28(2):77-83. doi: 10.1159/000099153
33. Rusnati M, Presta M (2007) Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des 13(20):2025-2044
34. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071-1121. doi: 10.1152/physrev.00038.2010
35. Korc M, Friesel RE (2009) The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 9(5):639-651
36. Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281(37):27292-27305. doi: 10.1074/jbc.M600448200
37. Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem 281(50):38343-38350. doi: 10.1074/jbc.M608764200
38. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N (2006) Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 281(5):2572-2577. doi: 10.1074/jbc.M510893200
39. Wang X, Fukuda T, Li W, Gao CX, Kondo A, Matsumoto A, Miyoshi E, Taniguchi N, Gu J (2009) Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice. J Biochem 145(5):643-651. doi: 10.1093/jb/mvp022
40. Murukesh N, Dive C, Jayson GC (2010) Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer 102(1):8-18. doi: 10.1038/sj.bjc.6605483
41. Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, Okuda Y, Segawa T, Suzuki H, Yamada N (2001) Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 281(2):562-568